Scar Prevention Using Fractional Carbon Dioxide Laser Treatment

Inclusion Criteria:

- Male or Females

- At least 18 and no more than 65 years old

- The surgical area closure in these subjects should be at least 4cm

- Type of surgery scheduled:

Site 1: Surgical area closure on thin skin, including areas that require motion (e.g.
face, hands, arms, thorax, etc.) Site 2: Surgical area closure on thick skin
(abdominoplasty procedure)

- Willing to comply with study dosing and complete the entire course of the study

Exclusion Criteria:

- Active bacterial, fungal, or viral infection in the treatment area

- Active cold sores, or herpes in the treatment area

- Recent excessive exposure to sunlight or artificial UV light (e.g.: use of tanning
beds/booths and/or sunbathing) or expectations of tanning during the time of the
study

- History of skin cancer, unless the surgical procedure of issue is for cancer
treatment purposes.

- History of or the presence of any skin condition/disease that might interfere with
the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema,
psoriasis)

- Treatment with a systemic retinoid within the past year (e.g., Accutane®, Roche
Dermatologics)

- History or presenting with a keloid scar

- Any current or recent treatment for cancer, unless the surgical procedure of issue is
for cancer treatment purposes.

- Any uncontrolled systemic disease. A potential subject in whom therapy for a systemic
disease is not yet stabilized will not be considered for entry into the study

- Significant history or current evidence of a medical, psychological or other disorder
that, in the investigator's opinion, would preclude enrollment into the study.

- Subject planning any other cosmetic procedure to the study area during the study
period, other than the treatments that will be performed by the investigator

- Female subject who is pregnant, nursing an infant or is less than 6 months after
termination of breast feeding

- Small surgical closure (<4cm)